Gelteq Limited Ordinary Net Income
| GELS Stock | 0.79 0.01 1.25% |
As of the 12th of February 2026, Gelteq Limited retains the Market Risk Adjusted Performance of (0.17), standard deviation of 7.16, and Risk Adjusted Performance of (0.02). Gelteq Limited technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Gelteq Limited Ordinary standard deviation and value at risk to decide if Gelteq Limited is priced fairly, providing market reflects its last-minute price of 0.79 per share. As Gelteq Limited Ordinary is a penny stock we also advise to confirm its jensen alpha numbers.
Gelteq Limited Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 94.0497 | Revenue | Earnings Share (0.51) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -6 M | -5.7 M | |
| Net Loss | -6 M | -5.7 M | |
| Net Loss | (0.43) | (0.45) | |
| Net Income Per E B T | 0.64 | 0.57 |
Gelteq | Net Income | Build AI portfolio with Gelteq Stock |
The evolution of Net Income for Gelteq Limited Ordinary provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Gelteq Limited compares to historical norms and industry peers.
Latest Gelteq Limited's Net Income Growth Pattern
Below is the plot of the Net Income of Gelteq Limited Ordinary over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Gelteq Limited Ordinary financial statement analysis. It represents the amount of money remaining after all of Gelteq Limited Ordinary operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Gelteq Limited's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gelteq Limited's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (6.65 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Gelteq Net Income Regression Statistics
| Arithmetic Mean | (1,949,078) | |
| Coefficient Of Variation | (118.73) | |
| Mean Deviation | 2,004,125 | |
| Median | (375,587) | |
| Standard Deviation | 2,314,165 | |
| Sample Variance | 5.4T | |
| Range | 6.3M | |
| R-Value | (0.84) | |
| Mean Square Error | 1.7T | |
| R-Squared | 0.71 | |
| Significance | 0.000024 | |
| Slope | (385,316) | |
| Total Sum of Squares | 85.7T |
Gelteq Net Income History
Other Fundumenentals of Gelteq Limited Ordinary
Gelteq Limited Net Income component correlations
Gelteq Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Gelteq Limited is extremely important. It helps to project a fair market value of Gelteq Stock properly, considering its historical fundamentals such as Net Income. Since Gelteq Limited's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Gelteq Limited's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Gelteq Limited's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Pharmaceuticals market expansion? Will Gelteq introduce new products? Factors like these will boost the valuation of Gelteq Limited. Market participants price Gelteq higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Gelteq Limited listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Revenue Per Share | Quarterly Revenue Growth 0.594 | Return On Assets | Return On Equity |
The market value of Gelteq Limited Ordinary is measured differently than its book value, which is the value of Gelteq that is recorded on the company's balance sheet. Investors also form their own opinion of Gelteq Limited's value that differs from its market value or its book value, called intrinsic value, which is Gelteq Limited's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Gelteq Limited's market value can be influenced by many factors that don't directly affect Gelteq Limited's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gelteq Limited's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gelteq Limited is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Gelteq Limited's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Gelteq Limited 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gelteq Limited's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gelteq Limited.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Gelteq Limited on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Gelteq Limited Ordinary or generate 0.0% return on investment in Gelteq Limited over 90 days. Gelteq Limited is related to or competes with Biofrontera, Immuron, Cocrystal Pharma, Sunshine Biopharma, ProPhase Labs, Aytu BioScience, and Imunon. Gelteq Limited is entity of United States More
Gelteq Limited Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gelteq Limited's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gelteq Limited Ordinary upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 55.89 | |||
| Value At Risk | (7.34) | |||
| Potential Upside | 6.9 |
Gelteq Limited Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gelteq Limited's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gelteq Limited's standard deviation. In reality, there are many statistical measures that can use Gelteq Limited historical prices to predict the future Gelteq Limited's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (1.08) | |||
| Treynor Ratio | (0.18) |
Gelteq Limited February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.17) | |||
| Mean Deviation | 4.25 | |||
| Coefficient Of Variation | (3,092) | |||
| Standard Deviation | 7.16 | |||
| Variance | 51.21 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (1.08) | |||
| Treynor Ratio | (0.18) | |||
| Maximum Drawdown | 55.89 | |||
| Value At Risk | (7.34) | |||
| Potential Upside | 6.9 | |||
| Skewness | 2.89 | |||
| Kurtosis | 15.2 |
Gelteq Limited Ordinary Backtested Returns
Gelteq Limited Ordinary holds Efficiency (Sharpe) Ratio of -0.0201, which attests that the entity had a -0.0201 % return per unit of risk over the last 3 months. Gelteq Limited Ordinary exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gelteq Limited's Risk Adjusted Performance of (0.02), standard deviation of 7.16, and Market Risk Adjusted Performance of (0.17) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.31, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Gelteq Limited will likely underperform. At this point, Gelteq Limited Ordinary has a negative expected return of -0.15%. Please make sure to check out Gelteq Limited's maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Gelteq Limited Ordinary performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.58 |
Modest predictability
Gelteq Limited Ordinary has modest predictability. Overlapping area represents the amount of predictability between Gelteq Limited time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gelteq Limited Ordinary price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current Gelteq Limited price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Gelteq Limited Ordinary reported net income of (6.65 Million). This is 101.95% lower than that of the Pharmaceuticals sector and 98.27% lower than that of the Health Care industry. The net income for all United States stocks is 101.16% higher than that of the company.
Gelteq Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gelteq Limited's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gelteq Limited could also be used in its relative valuation, which is a method of valuing Gelteq Limited by comparing valuation metrics of similar companies.Gelteq Limited is currently under evaluation in net income category among its peers.
Gelteq Fundamentals
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.15 | ||||
| Operating Margin | (29.69) % | ||||
| Current Valuation | 11.03 M | ||||
| Shares Outstanding | 10.71 M | ||||
| Shares Owned By Insiders | 47.52 % | ||||
| Shares Owned By Institutions | 0.86 % | ||||
| Number Of Shares Shorted | 130.04 K | ||||
| Price To Book | 0.74 X | ||||
| Price To Sales | 20.44 X | ||||
| Revenue | 165.65 K | ||||
| Gross Profit | 297.74 K | ||||
| EBITDA | (3.53 M) | ||||
| Net Income | (6.65 M) | ||||
| Total Debt | 4.22 M | ||||
| Book Value Per Share | 1.11 X | ||||
| Cash Flow From Operations | (5.52 M) | ||||
| Short Ratio | 0.05 X | ||||
| Earnings Per Share | (0.51) X | ||||
| Market Capitalization | 8.45 M | ||||
| Total Asset | 21.48 M | ||||
| Retained Earnings | (18.14 M) | ||||
| Working Capital | (4.13 M) | ||||
| Net Asset | 21.48 M |
About Gelteq Limited Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gelteq Limited Ordinary's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gelteq Limited using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gelteq Limited Ordinary based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gelteq Stock Analysis
When running Gelteq Limited's price analysis, check to measure Gelteq Limited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gelteq Limited is operating at the current time. Most of Gelteq Limited's value examination focuses on studying past and present price action to predict the probability of Gelteq Limited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gelteq Limited's price. Additionally, you may evaluate how the addition of Gelteq Limited to your portfolios can decrease your overall portfolio volatility.